Detailed Narrative
Strong Performance Driven by U.S. State and Local Customers
908 Devices reported Q2 FY26 revenue of $16.1 million, a 23% year-over-year increase. This growth was significantly bolstered by U.S. state and local customers, who accounted for over half of the quarter's revenues. This momentum is attributed to continued funding support for modernizing detection capabilities, particularly in response to the fentanyl crisis and emerging synthetic drugs, indicating a durable growth trajectory in this segment.
Profitability Improvements and Cost Structure Initiatives
The company demonstrated meaningful progress in profitability, with adjusted EBITDA loss improving by 50% year-over-year to less than $2 million. This was a direct result of cost structure initiatives implemented in the previous year. Adjusted gross margin also saw an increase of approximately 85 basis points to 57%, driven by higher product revenue volume, decreased facility costs, and a favorable shift in channel mix towards lower-cost U.S. state and local placements.
Strategic Acquisition of NearLab and Revenue Durability
The acquisition of NearLab in May 2026 is a key component of 908 Devices' strategy to strengthen revenue durability by building a more predictable, recurring revenue mix. NearLab introduces an AI-powered, subscription-based, cloud-connected near-infrared spectroscopy platform, complementing the existing narcotics detection portfolio. Within 60 days post-acquisition, over 35 NearLab devices were sold, each with a multi-year software subscription, meeting initial expectations and highlighting the potential for a recurring revenue model across the broader portfolio.
Scaling Proven Platforms: Viper and MX-908 Success
The company is successfully scaling its proven platforms, with Viper and MX-908 devices driving modernization efforts. Viper shipments exceeded 35 units in Q2, with a goal of over 100 for the year, securing competitive share and leveraging U.S. State Department funding for international missions. The MX-908 saw a significant win with 15 devices purchased by the Texas Department of Criminal Justice, demonstrating the 'engage, prove value, expand' playbook. A $6 million protector order in July further validates this strategy.
Extending Platform Leadership with Xplor
Xplor, the company's gas and vapor detection device, is extending platform leadership by addressing unmet needs in greenfield markets. Placements grew nearly 70% over the last 12 months, driven by rising HAZMAT incidents and SABURNI defense demand. The device's ability to identify and quantify hazardous vapors in real-time has led to significant deployments, including at the FIFA World Cup and for the Danish Defense Acquisition and Logistics Organization, showcasing its differentiated capabilities.
AVCAD Program Update and Future Outlook
The U.S. military AVCAD program is undergoing next steps, with the government considering commercially available products due to procurement reform prioritizing speed and flexibility. While this has led to the program being excluded from current 2026 guidance, management remains confident in winning the opportunity, either in partnership with Smith's Detection or directly with the commercial MX-908. The company views this as a long-term $10 million-plus opportunity, with clarity expected as the government's fiscal year closes on October 1st.